Literature DB >> 27754869

The Stalk Domain of NKp30 Contributes to Ligand Binding and Signaling of a Preassembled NKp30-CD3ζ Complex.

Stefanie Memmer1,2, Sandra Weil1,2, Steffen Beyer2, Tobias Zöller3, Eike Peters2,4, Jessica Hartmann5, Alexander Steinle3, Joachim Koch6,2,7.   

Abstract

The natural cytotoxicity receptor (NCR) NKp30 (CD337) is a key player for NK cell immunosurveillance of infections and cancer. The molecular details of ligand recognition and its connection to CD3ζ signaling remain unsolved. Here, we show that the stalk domain (129KEHPQLGAGTVLLLR143) of NKp30 is very sensitive to sequence alterations, as mutations lead to impaired ligand binding and/or signaling capacity. Surprisingly, the stalk domains of NKp30 and NKp46, another NCR employing CD3ζ for signaling, were not exchangeable without drastic deficiencies in folding, plasma membrane targeting, and/or ligand-induced receptor signaling. Further mutational studies, N-glycosylation mapping, and plasma membrane targeting studies in the absence and presence of CD3ζ suggest two interconvertible types of NCR-CD3ζ assemblies: 1) a signaling incompetent structural NKp30-CD3ζ complex and 2) a ligand-induced signaling competent NKp30-CD3ζ complex. Moreover, we propose that ligand binding triggers translocation of Arg-143 from the membrane interface into the membrane to enable alignment with oppositely charged aspartate residues within CD3ζ and activation of CD3ζ-signaling.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cell signaling; cell surface receptor; membrane protein; natural killer cells (NK cells); protein-protein interaction; receptor modification; receptor regulation

Mesh:

Substances:

Year:  2016        PMID: 27754869      PMCID: PMC5207244          DOI: 10.1074/jbc.M116.742981

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

Review 1.  Surface NK receptors and their ligands on tumor cells.

Authors:  Lorenzo Moretta; Cristina Bottino; Daniela Pende; Roberta Castriconi; Maria Cristina Mingari; Alessandro Moretta
Journal:  Semin Immunol       Date:  2006-05-26       Impact factor: 11.130

2.  The short extracellular domain of the T cell receptor zeta chain is involved in assembly and signal transduction.

Authors:  L Bolliger; B Johansson; E Palmer
Journal:  Mol Immunol       Date:  1997 Aug-Sep       Impact factor: 4.407

3.  Mapping the ends of transmembrane segments in a polytopic membrane protein. Scanning N-glycosylation mutagenesis of extracytosolic loops in the anion exchanger, band 3.

Authors:  M Popov; L Y Tam; J Li; R A Reithmeier
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

4.  Tumor-released Galectin-3, a soluble inhibitory ligand of human NKp30, plays an important role in tumor escape from NK cell attack.

Authors:  Wei Wang; Huaijian Guo; Jianlin Geng; Xiaodong Zheng; Haiming Wei; Rui Sun; Zhigang Tian
Journal:  J Biol Chem       Date:  2014-10-14       Impact factor: 5.157

5.  Identification of a cellular ligand for the natural cytotoxicity receptor NKp44.

Authors:  Florence Baychelier; Alexis Sennepin; Myriam Ermonval; Karim Dorgham; Patrice Debré; Vincent Vieillard
Journal:  Blood       Date:  2013-08-19       Impact factor: 22.113

6.  A soluble fragment of the tumor antigen BCL2-associated athanogene 6 (BAG-6) is essential and sufficient for inhibition of NKp30 receptor-dependent cytotoxicity of natural killer cells.

Authors:  Janina Binici; Jessica Hartmann; Julia Herrmann; Christine Schreiber; Steffen Beyer; Günnur Güler; Vitali Vogel; Franz Tumulka; Rupert Abele; Werner Mäntele; Joachim Koch
Journal:  J Biol Chem       Date:  2013-10-16       Impact factor: 5.157

7.  Requirements for cell surface expression of the human TCR/CD3 complex in non-T cells.

Authors:  C Hall; B Berkhout; B Alarcon; J Sancho; T Wileman; C Terhorst
Journal:  Int Immunol       Date:  1991-04       Impact factor: 4.823

8.  Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6.

Authors:  Yili Li; Qian Wang; Roy A Mariuzza
Journal:  J Exp Med       Date:  2011-03-21       Impact factor: 14.307

9.  p46, a novel natural killer cell-specific surface molecule that mediates cell activation.

Authors:  S Sivori; M Vitale; L Morelli; L Sanseverino; R Augugliaro; C Bottino; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

10.  The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans.

Authors:  Cameron S Brandt; Myriam Baratin; Eugene C Yi; Jacob Kennedy; Zeren Gao; Brian Fox; Betty Haldeman; Craig D Ostrander; Tomonori Kaifu; Christian Chabannon; Alessandro Moretta; Robert West; Wenfeng Xu; Eric Vivier; Steven D Levin
Journal:  J Exp Med       Date:  2009-06-15       Impact factor: 14.307

View more
  3 in total

1.  Reconstitution of a ligand-binding competent murine NKp30 receptor.

Authors:  Stefanie Memmer; Sandra Weil; Joachim Koch
Journal:  Immunogenetics       Date:  2017-08-07       Impact factor: 2.846

Review 2.  Regulation of the Functions of Natural Cytotoxicity Receptors by Interactions with Diverse Ligands and Alterations in Splice Variant Expression.

Authors:  Tatiana Pazina; Avishai Shemesh; Michael Brusilovsky; Angel Porgador; Kerry S Campbell
Journal:  Front Immunol       Date:  2017-03-30       Impact factor: 7.561

Review 3.  NKp30 - A prospective target for new cancer immunotherapy strategies.

Authors:  Pedro F Pinheiro; Gonçalo C Justino; M Matilde Marques
Journal:  Br J Pharmacol       Date:  2020-08-26       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.